Investigating the Miracle Biologic Lecanemab for Alzheimer's Disease - Part 5

Lecanemab’s Phase 3 trial: ethics, flip flops and EMA’s decision

Ethics

 The phase III trial BAN2401-G000-301 was registered in EudraCT (the EU register) and given the Number 2018-004739-58

In the US ClinicalTrials.gov, you find it here under the number NCT03887455 “A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)”

It’s not unusual for the TTE office researc…